FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100874814> ?p ?o ?g. }

• W2100874814 endingPage "310" @default.
• W2100874814 startingPage "304" @default.
• W2100874814 abstract "PURPOSE The antiestrogen tamoxifen is effective in therapy for breast cancer. However, its use is limited by the eventual development of acquired tamoxifen resistance in many patients. The mechanisms responsible for tamoxifen resistance remain unknown; loss of estrogen receptor (ER), selection of hormone-independent breast cancer clones, or alterations in serum tamoxifen levels after long-term use do not explain acquired resistance in most patients. Using an experimental model in which human breast cancer cells develop resistance in athymic mice treated with tamoxifen, we have recently shown that acquired resistance is associated with markedly reduced cellular concentrations of tamoxifen and by isomerization of the trans-4-hydroxy metabolite to the less potent cis isomer. MATERIALS AND METHODS Using a sensitive high-performance liquid chromatography (HPLC) assay, we have now measured levels of tamoxifen and its major metabolites in a series of 14 tumors from patients treated with tamoxifen. The duration of therapy ranged from 1 month to 6 years. RESULTS Tumor tamoxifen levels varied over a wide range. Low concentrations were observed in tumors from eight patients, all demonstrating progressive disease at the time of biopsy after a minimum duration of treatment of 6 months. Six tumors had moderate to high tamoxifen levels, two from patients responding to tamoxifen, one from a patient with stable disease, and three from patients with disease progression. Both the cis and trans isomers of the potent antiestrogenic metabolite 4-hydroxy-tamoxifen were detected in 11 tumors. Six tumors had high ratios of the cis to trans isomer (1.10:2.06), all from patients not responding to tamoxifen. The five tumors with low cis:trans ratios included the two tumors from responding patients and three from patients with progression. All but one of the 11 nonresponding patients had either a low tumor tamoxifen level, a high cis:trans ratio, or both. CONCLUSION This study clearly demonstrates a wide range of tumor tamoxifen levels and accumulation of the less antiestrogenic cis isomer of 4-hydroxytamoxifen in some patients on tamoxifen therapy. Additional study is necessary to determine if these metabolic profiles are related to the development of tamoxifen resistance." @default.
• W2100874814 created "2016-06-24" @default.
• W2100874814 creator A5009806553 @default.
• W2100874814 creator A5018428197 @default.
• W2100874814 creator A5025530600 @default.
• W2100874814 creator A5027914471 @default.
• W2100874814 creator A5032951976 @default.
• W2100874814 date "1992-02-01" @default.
• W2100874814 modified "2023-09-30" @default.
• W2100874814 title "Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients." @default.
• W2100874814 cites W1482458857 @default.
• W2100874814 cites W1565283549 @default.
• W2100874814 cites W1600830158 @default.
• W2100874814 cites W1865075142 @default.
• W2100874814 cites W1985428088 @default.
• W2100874814 cites W1991458195 @default.
• W2100874814 cites W2001269969 @default.
• W2100874814 cites W2002041504 @default.
• W2100874814 cites W2040532631 @default.
• W2100874814 cites W2041351305 @default.
• W2100874814 cites W2080931196 @default.
• W2100874814 cites W2122934729 @default.
• W2100874814 cites W2125324517 @default.
• W2100874814 cites W2273833263 @default.
• W2100874814 cites W2901368272 @default.
• W2100874814 doi "https://doi.org/10.1200/jco.1992.10.2.304" @default.
• W2100874814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1732430" @default.
• W2100874814 hasPublicationYear "1992" @default.
• W2100874814 type Work @default.
• W2100874814 sameAs 2100874814 @default.
• W2100874814 citedByCount "138" @default.
• W2100874814 countsByYear W21008748142012 @default.
• W2100874814 countsByYear W21008748142013 @default.
• W2100874814 countsByYear W21008748142014 @default.
• W2100874814 countsByYear W21008748142015 @default.
• W2100874814 countsByYear W21008748142016 @default.
• W2100874814 countsByYear W21008748142017 @default.
• W2100874814 countsByYear W21008748142018 @default.
• W2100874814 countsByYear W21008748142019 @default.
• W2100874814 countsByYear W21008748142022 @default.
• W2100874814 countsByYear W21008748142023 @default.
• W2100874814 crossrefType "journal-article" @default.
• W2100874814 hasAuthorship W2100874814A5009806553 @default.
• W2100874814 hasAuthorship W2100874814A5018428197 @default.
• W2100874814 hasAuthorship W2100874814A5025530600 @default.
• W2100874814 hasAuthorship W2100874814A5027914471 @default.
• W2100874814 hasAuthorship W2100874814A5032951976 @default.
• W2100874814 hasConcept C121608353 @default.
• W2100874814 hasConcept C126322002 @default.
• W2100874814 hasConcept C143998085 @default.
• W2100874814 hasConcept C2776067312 @default.
• W2100874814 hasConcept C2777176818 @default.
• W2100874814 hasConcept C2777477808 @default.
• W2100874814 hasConcept C502942594 @default.
• W2100874814 hasConcept C530470458 @default.
• W2100874814 hasConcept C71924100 @default.
• W2100874814 hasConcept C84606932 @default.
• W2100874814 hasConceptScore W2100874814C121608353 @default.
• W2100874814 hasConceptScore W2100874814C126322002 @default.
• W2100874814 hasConceptScore W2100874814C143998085 @default.
• W2100874814 hasConceptScore W2100874814C2776067312 @default.
• W2100874814 hasConceptScore W2100874814C2777176818 @default.
• W2100874814 hasConceptScore W2100874814C2777477808 @default.
• W2100874814 hasConceptScore W2100874814C502942594 @default.
• W2100874814 hasConceptScore W2100874814C530470458 @default.
• W2100874814 hasConceptScore W2100874814C71924100 @default.
• W2100874814 hasConceptScore W2100874814C84606932 @default.
• W2100874814 hasIssue "2" @default.
• W2100874814 hasLocation W21008748141 @default.
• W2100874814 hasLocation W21008748142 @default.
• W2100874814 hasOpenAccess W2100874814 @default.
• W2100874814 hasPrimaryLocation W21008748141 @default.
• W2100874814 hasRelatedWork W1212251450 @default.
• W2100874814 hasRelatedWork W1771722205 @default.
• W2100874814 hasRelatedWork W1965243176 @default.
• W2100874814 hasRelatedWork W1983499475 @default.
• W2100874814 hasRelatedWork W2103643613 @default.
• W2100874814 hasRelatedWork W2417814488 @default.
• W2100874814 hasRelatedWork W2478630076 @default.
• W2100874814 hasRelatedWork W2496465202 @default.
• W2100874814 hasRelatedWork W4309488699 @default.
• W2100874814 hasRelatedWork W856761886 @default.
• W2100874814 hasVolume "10" @default.
• W2100874814 isParatext "false" @default.
• W2100874814 isRetracted "false" @default.
• W2100874814 magId "2100874814" @default.
• W2100874814 workType "article" @default.